Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study.

Literature DB >> 16973806

Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study.

J Arnlöv, J C Evans, E J Benjamin, M G Larson, D Levy, P Sutherland, D A Siwik, T J Wang, W S Colucci, R S Vasan.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2006 PMID： 16973806 PMCID： PMC1861062 DOI： 10.1136/hrt.2005.081406

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

5 in total

1. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function.

Authors: Chisato Suezawa; Shozo Kusachi; Takashi Murakami; Kenichi Toeda; Satoshi Hirohata; Keigo Nakamura; Keizo Yamamoto; Kazuya Koten; Toru Miyoshi; Yasushi Shiratori
Journal: J Lab Clin Med Date: 2005-01

2. Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.

Authors: G Li; Y F Chen; S S Kelpke; S Oparil; J A Thompson
Journal: Circulation Date: 2000-06-27 Impact factor: 29.690

3. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.

Authors: Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal: J Biol Chem Date: 2004-07-07 Impact factor: 5.157

4. An investigation of coronary heart disease in families. The Framingham offspring study.

Authors: W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal: Am J Epidemiol Date: 1979-09 Impact factor: 4.897

5. Osteopontin expression in cardiovascular diseases.

Authors: C M Giachelli; L Liaw; C E Murry; S M Schwartz; M Almeida
Journal: Ann N Y Acad Sci Date: 1995-04-21 Impact factor: 5.691

5 in total

8 in total

Review 1. Matricellular proteins in cardiac adaptation and disease.

Authors: Nikolaos G Frangogiannis
Journal: Physiol Rev Date: 2012-04 Impact factor: 37.312

2. Osteopontin: an emerging therapeutic target in uraemic vascular disease.

Authors: Xin Zhang; Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal: Cardiovasc Res Date: 2013-04-23 Impact factor: 10.787

3. Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.

Authors: Hala Abdel-Hameed Abdel-Azeez; Manar Al-Zaky
Journal: J Clin Lab Anal Date: 2010 Impact factor: 2.352

Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study.

1. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function.

2. Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.

3. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.

4. An investigation of coronary heart disease in families. The Framingham offspring study.

5. Osteopontin expression in cardiovascular diseases.

Review 1. Matricellular proteins in cardiac adaptation and disease.

2. Osteopontin: an emerging therapeutic target in uraemic vascular disease.

3. Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.

4. Extracellular matrix remodelling in myocardial hypertrophy and failure : focus on osteopontin.

5. Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery.

6. Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial.

Review 7. Sex-related differences in contemporary biomarkers for heart failure: a review.

8. Assessment of brain-derived neurotrophic factor and osteopontin in a healthy pediatric population.